Carlson Family Foundation

Carlson Family Foundation

Carlson Family Foundation

Date Founded




Charitable Causes

Private Grantmaking Foundations


Investment Services & Portfolio Management
Social Interest

Company Description

The Curtis L. Carlson Foundation was established in 1950, by its founder, Curtis L. Carlson. Later, the name was changed to the Carlson Family Foundation to extend the entire family in the founder’s long-term philanthropic vision of giving back to the community which gave to him. The Carlson Family Foundation represents the commitment of the Carlson family to give charitably to humanitarian and community affairs. Through investments in education, mentoring, children and youth at risk, and youth mentoring, the Carlson Family Foundation actively participates in creating strong and healthy communities, and a competitive workforce.

Contact Data
Trying to get in touch with decision makers at Carlson Family Foundation? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Grants Manager

Executive Assistant

Executive Director

Head of Investments

Senior Director, Portfolio Management

Vice President

Investment Analyst

Board of Trustees

Co-Founder at

Founder at Geoffrey Carlson Gage Brand Communications

Member, Board of Trustees at Carlson Family Foundation

Chief Executive Officer at Carlson Holdings, Inc.

Former Vice President at Carlson Family Foundation

Paths to Carlson Family Foundation
Potential Connections via
Relationship Science
Carlson Family Foundation
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Details Hidden

Transoma Medical, Inc., headquartered in St. Paul, Minnesota, is a medical technology company engaged in developing, manufacturing and distributing implantable, wireless diagnostic and monitoring systems. Transoma is focused specifically on diagnostic and monitoring technology and dedicated to providing physicians with information needed to accurately and quickly diagnose unexplained, infrequent symptoms and to monitor changing, often asymptomatic complex arrhythmias.Transoma has an extensive technology platform based on more than 20 years experience in developing implantable wireless diagnostic systems for use in biomedical research. These innovative tools have played a key role in drug discovery, pre-clinical evaluation of safety and efficacy, and other academic and government basic research. Customers have turned to DSI for more accurate, timely physiological data, highly humane research practices, and faster times to market. In 2003 the Patient Management division was formed utilizing this proven technology platform and paving the way for the formation of Transoma Medical.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Carlson Family Foundation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Carlson Family Foundation's profile does not indicate a business or promotional relationship of any kind between RelSci and Carlson Family Foundation.